This activity is jointly provided by Parkinson & Movement Disorder Alliance (PMD Alliance) and The Association of Movement Disorder Advanced Practice Providers (AMDAPP).

The AMDAPP Annual CME Conference, titled "Advancing Movement Disorder Care - Innovations & Best Practices for APPs," is a dynamic two-day event designed to enhance the skills and knowledge of advanced practice providers (APPs) in movement disorder care.  The conference provides a blend of educational sessions, interactive workshops, and networking opportunities.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Parkinson & Movement Disorder Alliance (PMD Alliance) and The Association of Movement Disorder Advanced Practice Providers (AMDAPP). PMD Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physician Continuing Medical Education

PMD Alliance designates this course for a maximum of 13.25 AMA PRA Category 1.0 Credit(s)™.  

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

This course is for movement disorder specialists, neurologists, advanced practice providers, and other healthcare professionals involved in the care of patients with a movement or related disorder.

Educational Objectives

After completing this activity, the participant should be better able to:

• Develop advanced diagnostic skills to differentiate Parkinson’s disease from other movement disorders, ensuring timely and accurate diagnoses for improved patient outcomes.
• Apply current evidence-based treatments in the management of movement disorders, including pharmacologic advancements and non-pharmacologic interventions, to enhance individualized patient care.
• Integrate comprehensive and holistic strategies within movement disorder treatment plans to provide care that addresses both the physical and psychological needs of patients including their social history and personalized needs with empathy to both the patient and care partner.
• Demonstrate competence in device-based therapies, including Deep Brain Stimulation (DBS) programming and intrathecal pump management, through hands-on workshops designed to improve procedural skills and patient outcomes.
• Perform injection techniques for conditions such as sialorrhea and dystonia effectively and safely, contributing to better symptom management and patient comfort.
• Identify and address hyperkinetic movement disorders by applying the latest treatment approaches, enhancing quality of life for patients experiencing these conditions.
• Explore the roles and contributions of APPs within multidisciplinary care teams, and develop leadership skills to foster improved collaboration and communication across care providers.
• Enhance strategies for managing atypical presentations of movement disorders, using evidence-based approaches to refine diagnostic and treatment approaches.
• Assess the latest updates on certification and professional development within movement disorders to support continued growth and competency among APPs.
• Increase confidence in applying new therapies and clinical insights to ensure APPs are prepared to adopt and implement innovative care strategies that meet evolving patient needs.

Faculty

Leonardo Brito
Clarisse Goas 
Sherrie Gould 
Meredith Hatcher
Katie Henke
Matt Hermiz
Traci Hornbeck
Kathy Huynh 
Andrew Imbus
Cheryl Kyinn
Arita McCoy 
Mara McCrossin 
Matthew Moore
Victoria Segro 
Krista Stauffer
Kelly Tritz 
Maileen Ulep-Reed 
Monica Volz
Pam Zeilman

Disclosure of Relevant Financial Relationships

Parkinson and Movement Disorder Alliance (PMD Alliance) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies.  PMD Alliance is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CME activity:

• Leonardo Brito
• Speakers’ Bureau, consultant, and/or advisory board member for Medtronic

• Clarisse Goas
• Has no disclosures to report

• Sherrie Gould
• Speakers’ Bureau, consultant, and/or advisory board member for Acadia, Amneal, Medtronic, Abbott, and Boston Scientific

• Meredith Hatcher
• Speakers’ Bureau, consultant, and/or advisory board member for AbbVie, Amneal, Acorda, Abbott, Medtronic, Supernus

• Katie Henke
• Has no disclosures to report

• Matt Hermiz
• Has no disclosures to report

• Traci Hornbeck
• Speakers’ Bureau, consultant, and/or advisory board member for Medtronic and Boston Scientific

• Kathy Huynh
• Speakers’ Bureau, consultant, and/or advisory board member for Boston Scientific, Medtronic, and Acadia

• Andrew Imbus
• Speakers’ Bureau, consultant, and/or advisory board member for Abbott Neuro Stimulation, Boston Scientific, Amneal, and AbbVie

• Cheryl Kyinn
• Speakers’ Bureau, consultant, and/or advisory board member for AbbVie, Acadia, Amneal, and Supernus

• Arita McCoy
• Has no disclosures to report

• Mara McCrossin
• Has no disclosures to report

• Mathew Moore
• Has no disclosures to report

• Vicki Segro
• Has no disclosures to report

• Krista Stauffer
• Has no disclosures to report

• Kelly Tritz
• Has no disclosures to report

• Maileen Ulep-Reed
• Has no disclosures to report

• Monica Volz
• Speakers’ Bureau, consultant, and/or advisory board member for Boston Scientific and Medtronic

• Pam Zeilman
• Has no disclosures to report

Planners reported the following relevant financial relationships with ineligible entities related to the educational content of this CME activity:

• Alexis Santangelo
• Grant or research support from Bial Pharma
• Speakers’ Bureau, consultant, and/or advisory board member for AbbVie, Amneal, and Medtronic

• Jason Rivera, MPH
• No disclosures to report

• Clarisse Goas, NP
• No disclosures to report

• Erin Zinn
• Speakers’ Bureau, consultant, and/or advisory board member for Medtronic and Supernus

• Pam Zeilman
• Has no disclosures to report

• Andrew Imbus
• Speakers’ Bureau, consultant, and/or advisory board member for Abbott Neuro Stimulation, Boston Scientific, Amneal, and AbbVie

PMD Alliance has received non-CME educational funding and support from ineligible companies.  This support is not tied to continuing medical education.  These relationships have been mitigated and do not influence CME content.

All identified relevant financial relationships are thoroughly vetted and mitigated according to PMD Alliance CME Program standard operating procedures. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.  The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Request for Credit

In order to obtain your CME certificate, please follow the directions provided at the conclusion of the course.  

If you have questions regarding the certification of this activity, please contact PMD Alliance at education@pmdalliance.org